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Exploring the Microbiome of Healthy and Diseased Peri-Implant Sites Using
Illumina Sequencing
Abstract

Aim
To compare the microbiome of healthy (H) and diseased (P) peri-implant sites and determine the core
peri-implant microbiome.

Materials and Methods
Submucosal biofilms from 32 H and 35 P sites were analyzed using 16S rRNA sequencing (MiSeq,
Illumina), QIIME and HOMINGS. Differences between groups were determined using Principal Coordinate
Analysis (PCoA), t-tests and Wilcoxon rank sum test and FDR-adjusted. The peri-implant core microbiome
was determined.

Results
PCoA showed partitioning between H and P at all taxonomic levels. Bacteroidetes, Spirochetes and
Synergistetes were higher in P, while Actinobacteria prevailed in H (p<0.05). Porphyromonas and
Treponema were more abundant in P and while Rothia and Neisseria were higher in H (p<0.05). The core
peri-implant microbiome contained Fusobacterium, Parvimonas and Campylobacter sp. T. denticola and
P. gingivalis levels were higher in P, as well as F. alocis, F fastidiosum and T. maltophilum (p<0.05).

Conclusion
The peri-implantitis microbiome is commensal-depleted and pathogen-enriched, harboring traditional and
new pathogens. The core peri-implant microbiome harbors taxa from genera often associated with
periodontal inflammation.
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Abstract
Aim—To compare the microbiome of healthy (H) and diseased (P) peri-implant sites and
determine the core peri-implant microbiome.
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Materials and Methods—Submucosal biofilms from 32 H and 35 P sites were analyzed using
16S rRNA sequencing (MiSeq, Illumina), QIIME and HOMINGS. Differences between groups
were determined using Principal Coordinate Analysis (PCoA), t-tests and Wilcoxon rank sum test
and FDR-adjusted. The peri-implant core microbiome was determined.
Results—PCoA showed partitioning between H and P at all taxonomic levels. Bacteroidetes,
Spirochetes and Synergistetes were higher in P, while Actinobacteria prevailed in H (p<0.05).
Porphyromonas and Treponema were more abundant in P and while Rothia and Neisseria were
higher in H (p<0.05). The core peri-implant microbiome contained Fusobacterium, Parvimonas
and Campylobacter sp. T. denticola and P. gingivalis levels were higher in P, as well as F. alocis, F
fastidiosum and T. maltophilum (p<0.05).
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Conclusion—The peri-implantitis microbiome is commensal-depleted and pathogen-enriched,
harboring traditional and new pathogens. The core peri-implant microbiome harbors taxa from
genera often associated with periodontal inflammation.
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Introduction
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The widespread use of implants has led to an increase in the number of cases of biofilmmediated peri-implant diseases, particularly peri-implantitis. Although long-term
longitudinal studies indicate that implant therapy presents success rates of 95% – 99%
(Moraschini et al., 2015, Vigolo et al., 2015) recent publications have shown a prevalence of
peri-implantitis of at least 20% (Derks et al., 2016b, Derks et al., 2016a, Derks & Tomasi,
2015, Mombelli et al., 2012, Derks & Tomasi, 2014). It has been suggested that periimplantitis progresses in non-linear patterns, and for the majority of cases, the onset occurs
within 3 years of function (Derks et al. 2016b). Peri-implantitis treatment is further
complicated by the limited knowledge of its microbial etiology. While several studies have
shown microbial similarities between periodontitis and peri-implantitis (Carcuac et al., 2016,
Charalampakis & Belibasakis, 2015, Mombelli & Decaillet, 2011), others have implicated
species not traditionally associated with periodontal/peri-implant diseases, such as
Helicobacter pylori, Haemophilus influenzae, Staphylococcus aureus and Staphylococcus
anaerobius in the etiology of peri-implantitis (Persson & Renvert 2014). The current poor
understanding of the microbial etiology and pathogenesis of peri-implantitis may help
explain the lack of effective treatment.

Author Manuscript
Author Manuscript

Most of the publications that investigated the microbial profiles of peri-implantitis employed
close-ended molecular approaches, which preclude the identification of potentially relevant
taxa that are not targeted by the technique. The use of 16S rRNA Illumina sequencing can
overcome this limitation by allowing an open-ended characterization of the microbiome
under study (Caporaso et al., 2012, Frey et al., 2014, Smith & Peay, 2014), at a coverage
depth 100 times greater than pyrosequencing, with a lower error rate and generating well
over 10 times as many reads as 454 GS FLX (Nelson et al., 2014). Because it combines
higher sequence quality at significantly lower cost per sequence, it has become the leading
sequencing platform for human microbiome sequencing studies (Amarasekara et al., 2015).
One limitation of 16S rRNA sequencing is that certain taxa cannot be distinguished with
species-level taxonomic resolution when the commonly employed QIIME pipeline is used
for the downstream taxonomic classification (Baker et al., 2003, Chakravorty et al., 2007,
Ong et al., 2013, Pei et al., 2010, Wang & Qian, 2009). To manage this limitation, we
analyzed the reads generated by MiSeq with HOMINGS in order to obtain species-level
data. HOMINGS is an in silico probe-based platform that can detect more than 600 bacterial
species from 16S rRNA reads (Belstrom et al., 2016a).
The objective of the present investigation was to compare the microbiome of healthy (H) and
diseased (P) peri-implant sites using 16S rRNA Illumina sequencing and HOMINGS and to
determine the peri-implant core microbiome.
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Materials and Methods
Patient recruitment

Author Manuscript

This study was approved by the Ethical Review Committee of the Canton of Zürich,
Switzerland (KEK-Nr: 2011-0159), and was conducted in accordance with the guidelines of
the world Medical Association Declaration of Helsinki. Peri-implantitis patients were
recruited as outpatients referred by private practitioners for the diagnosis and treatment of
peri-implant disease at the Interdisciplinary Peri-implantitis Unit, in the Center of Dental
Medicine at the University of Zürich. Patients presenting successful implants were recruited
from the maintenance clinic at the same institution. Potential participants were informed
about the aims of the study and were assured that their participation was voluntary. All
participants provided written informed consent. The inclusion criteria were good medical
health as evidenced by the medical history, being at least 18 years old and willing to
participate in the study. Exclusion criteria were as follows: periodontal or peri-implant
treatment within the past 12 months, systemic antibiotics use within the past 6 months,
pregnancy or lactation, and heavy smoking (>20 cigarettes/day).
Patients allocated to the peri-implantitis group presented at least one implant with postinsertion (i.e. at least one-year after loading) radiographic marginal bone loss of at least 2.0
mm mesially or distally, with concomitant bleeding on probing, according to the definitions
presented in the 6th European Workshop on Periodontology (Zitzmann & Berglundh, 2008).
Radiographic bone levels were recorded by measuring the distance from the implant
shoulder to the first visible bone to implant contact at the mesial and distal aspect of each
implant using periapical radiographs.

Author Manuscript

The successful implants group included implants with healthy surrounding soft and hard
tissues, determined by absence of pus and detectable radiographic bone loss, and functional
loading for at least one year. Gender and age were recorded, as well as plaque index (PI),
bleeding on probing (BOP), suppuration (SUP), probing pocket depth (PPD), clinical bone
loss (BL in mm), width of keratinized mucosa (KM), implant wear time, time since last
check up, implant system used and nature of reconstruction (single implant, fixed or
removable). The clinical parameters were measured at 6 sites per implant (mesio-, mid-,
disto-buccal and mesio-, mid-, disto-lingual/palatal; except for KM, where the palatal sites
were not measured).
Submucosal biofilm sample collection and nucleic acid isolation

Author Manuscript

Submucosal biofilm samples were collected from peri-implantitis sites (P) in peri-implantitis
patients and from healthy peri-implant sites (H) of participants presenting successful
implants. If multiple implants were present in a patient, one single implant was randomly
selected for sampling. Samples were obtained from the site with the deepest PPD. Prior to
sampling, the supramucosal areas of the implant and supra-structure were isolated using
cotton rolls, air-dried and had the supramucosal biofilm removed. Submucosal biofilm
samples were obtained with sterile Gracey curettes (Deppeler, Rolle, Switzerland). The
sample was immediately placed in a micro-centrifuge tube containing 0.1 ml of RNAse-free
TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.6) and stored at −80°C until analysis.

J Clin Periodontol. Author manuscript; available in PMC 2020 May 08.
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Bacterial nucleic acids were isolated using the Masterpure DNA purification kit (Epicentre,
Madison, WI, USA), preceded by an overnight incubation with lysozyme at 37°C. DNA
quality and amount were determined using a spectrophotometer and the Picogreen dsDNA
quantification assay (Invitrogen, Carlsbad, CA, USA).
16S rRNA gene sequencing with Illumina sequencing

Author Manuscript

Sample DNA was analyzed by sequencing the 16S rRNA gene V3-V4 hypervariable region
using MiSeq (Illumina, CA), according to the protocol described by (Caporaso et al., 2011).
In brief, 10–50 ng of DNA were PCR-amplified using the 341F/806R universal primers
targeting the V3-V4 hypervariable region: 341F (forward)
AATGATACGGCGACCACCGAGATCTACACTATGGTAATTGTCCTACGGGAGGCAGC
AG; 806R (reverse) CAAGCAGAAGACGGCATACGAGATTCCCTTGTCTCC
AGTCAGTCAGCCGGACTACHVGGGTWTCTAAT, where the ‘TCCCTTGTCTCC’
region represents the appropriate barcode sequences and the underlined bases make the PCR
products Illumina sequencing compatible. PCR samples were purified using AMPure beads
and 100 ng of each barcoded library were pooled, purified and quantified using a
bioanalyzer and qPCR. Then, 12 pM of each library mixture spiked with 20% PhiX was
loaded onto the MiSeq and sequenced. Samples that presented poor performance in the presequencing PCR amplification step were amplified by multiple displacement amplification
(Teles et al., 2007) using the Illustra GenomiPhi V2 DNA Amplification kit (GE Healthcare,
USA). Quality control of the reads was performed using FastQC. The paired end reads were
merged using Flash.
Taxonomic assignment

Author Manuscript

The reads generated using MiSeq were analyzed using the QIIME pipeline (Caporaso et al.
2010). In brief, the paired-end reads were merged using Flash. The libraries were split in
QIIME according to the barcodes used in the sequencing run and low-quality reads were
filtered out and chimeras were removed using UCHIME. Operational taxonomic units
(OTUs) were picked using the Human Oral Microbiome Database (HOMD) v13.2 as the
reference database (Chen et al. 2010) using a 97% similarity threshold. Taxonomy was
assigned using the Ribosomal Database Project (RDP) classifier trained on the HOMD v13.2
database with assignments required to meet a >80% confidence threshold. The phylum and
genus-level analyses were performed using QIIME.

Author Manuscript

For species-level analyses only, we employed HOMINGS, an in silico 16S rDNA probe
analysis that allows for species-level identification of sequencing datasets generated with
MiSeq (http://homings.forsyth.org) (Gomes et al., 2015). Species-specific, 16S rRNA-based
oligonucleotide “probes” were used in a Perl program based on text string search to identify
the frequency of oral bacterial targets. HOMINGS comprises 671 oligonucleotide probes of
17 to 40 bases that target 538 individual oral bacterial species/phylotypes or, in some cases,
a few closely-related taxa. (Belstrom et al., 2016a, Belstrom et al., 2016d).
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Author Manuscript

The demographic and clinical characteristics of the study population were analyzed using
the Fisher’s Exact Test or Student’s t-test. Effects of disease status on the peri-implant
microbiome were examined using Principal Coordinate Analysis (PCoA).

Author Manuscript

Significant differences in relative abundance (%) between the clinical groups were
determined at the phylum, genus, and species levels. Raw read counts were rarefied to the
minimum number of aligned reads. Only taxa that had at least 3 reads in at least 3 samples in
both clinical groups after rarefication were considered. Significant differences between the
healthy and peri-implantitis groups were determined by Wilcoxon rank sum test with FDRadjusted p-values <0.05. This rarefication and determination of significance was repeated
100 times. Taxa that were significant in 95% of these iterations were further considered in
the analyses. Interactions between those taxa and smoking, as well as implant type were
assessed using ANOVA.
The core microbiome of the dataset was determined based on taxa present with ≥0.1%
relative abundance in ≥50% of all samples, as determined by HOMINGS (Abusleme et al.,
2013). It was subdivided into 4 groups based on the taxa mean relative abundance in samples
in each clinical category. Taxa that were present in ≥50% of samples in either the H or P
groups, but were not part of the core microbiome considering all samples, constituted the
healthy or peri-implantitis core microbiomes, respectively.

Results
Demographic and clinical characteristics of the subjects

Author Manuscript

Eighty-two patients contributing with one implant per patient were initially included in the
investigation. Fifteen patients were excluded due to issues with microbial sampling. Finally,
the analysis of demographic and clinical data from the sampled population showed that the
groups comprising healthy (H, N=32) and diseased peri-implant sites (P, N=35) were wellbalanced for age, gender, implant wear, implant location and type of restoration (Table 1).
Non-smokers and smokers comprised 37.1% and 42.9% of the P group, respectively,
whereas in the H group these were 71.9% and 21.9%, respectively (p=0.03). Straumann was
the most frequently used implant system in both groups (71.9% in H and 47.1% in P), while
other systems (i.e., not Straumann or Branemark) were more common in P (35.3%) than in
H (3.1%) (p=0.003). Significant differences between the groups were observed for the
clinical parameters that defined them (p<0.0001).
Overall microbial sequencing results

Author Manuscript

Fifteen samples (7 in disease, 8 in health) were excluded from analysis due to the small
number of reads (<5,000). After quality control, chimera depletion and noise filtering,
7,297,772 reads (median/sample: 114,230; range: 5,055–212,299) were assigned into OTUs
(1.7% of them remained unassigned) and most of them (73.52%) ranged from 408 to 428 bp
in length. OTUs were classified into twelve phyla: Bacteroidetes (25.3%), Proteobacteria
(18.4%), Firmicutes (16.7%), Actinobacteria (15.6%), Fusobacteria (15.6%), Spirochaetes
(5.3%), Synergistetes (0.7%), Tenericutes (0.4%), TM7 (0.3%), SR1 (0.1%), Chloroflexi
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(0.01%) and GN02 (0.001%). These OTUs were further classified into 21 classes, 35 orders,
69 families and 94 genera, using QIIME. HOMINGS identified 85 genera and 210 species
using species-specific “probes”. A complete list of species detected in H and P samples can
be found in Supplemental Table 1.
Microbial profiles of healthy and diseased peri-implant sites

Author Manuscript

Diseased peri-implant sites presented higher diversity, compared to healthy sites
(Supplemental Fig. 1a). Healthy (H) and diseased (P) peri-implant sites presented distinct
microbial profiles at all taxonomic levels (Fig. 1a–c, Supplemental Fig. 1b). Diseased periimplant sites were primarily colonized by members of the phyla Bacteroides, Spirochetes
and Synergistetes, whereas healthy peri-implant sites mostly harbored taxa from the
Proteobacteria and Actinobacteria phyla (p<0.05, FDR-adjusted) (Fig. 1a). The genera
Porphyromonas (phylum Bacteroidetes), Treponema (phylum Spirochetes), Filifactor
(phylum Firmicutes), Fretibacterium (phylum Synergistetes and Tannerella (phylum
Bacteroidetes) were abundant in peri-implantitis and were present at a higher relative
abundance than those found in the H group (p<0.05, FDR-adjusted). In contrast,
Streptococcus (phylum Firmicutes), Veillonella (phylum Firmicutes), Rothia (phylum
Actinobacteria) and Haemophilus (phylum Proteobacteria) had higher relative abundance in
H sites (p<0.05, FDR-adjusted) (Fig. 1b). Peri-implantitis sites harbored higher levels of
classic pathogens (Fig. 1c), such as Tannerella forsythia, Treponema denticola and
Porphyromonas gingivalis (p<0.05, FDR-adjusted), as well as recently described new
putative pathogens, such as Filifactor alocis, Fretibacterium fastidiosum and Treponema
maltophilum. Implants adjacent to H sites were enriched for Rothia dentocariosa (Fig. 1c).

Author Manuscript

Analysis of the relative abundance of pathogenic and health-compatible species in individual
implants (Fig. 2 a–c) showed that red complex species (T. forsythia, P. gingivalis and T.
denticola) were present at high levels in most P samples compared to H samples (Fig. 2a),
whereas the opposite was observed for species considered compatible with periodontal/periimplant health, such as R. dentocariosa, Streptococcus sanguinis and Veillonella dispar (Fig.
2b). Furthermore, newly proposed periodontal pathogens, such as F. alocis, F. fastidiosum,
Eubacterium saphenum and T. maltophilum and as-of-yet uncultured taxa Desulfobulbus sp
ot 041, Fretibacterium sp ot 360 and Peptostreptococcacea sp ot 091 and 369 (Fig. 2c)
followed a colonization pattern similar to that of well-recognized periodontal pathogens (T.
forsythia, P. gingivalis and T. denticola) (Fig. 2b).

Author Manuscript

Next, we employed PCoA to assess the impact of peri-implant health and disease on the
local microbiome. A clear distinction between the microbial composition of H and P
implants at all taxonomic levels was observed (Fig. 3a–c). Even though it was not the
primary objective of the present study, we also explored the potential impact of smoking
status and implant system used on the peri-implant microbiome. When the smoking status
was incorporated in the analysis (Fig. 3b), it became apparent that the composition of the
microbiome of current smokers in the H microbiome was closer to that of peri-implantitis
cases than to that observed in successful implants. The impact of the implant system on the
local microbiome seemed to be less evident (Fig. 3c).

J Clin Periodontol. Author manuscript; available in PMC 2020 May 08.
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Because our results indicated that smoking and implant type could be possible confounders
when the microbiome of peri-implant health and disease was compared, potential
interactions between these parameters were also included in our statistical model. The
results revealed an interaction between smoking and disease status for T. socranskii and
Eubacterium saphenum, interactions between smoking and implant type for T. maltophilum
and E. saphenum, and interactions between disease status and implant type for T.
maltophilum.

Author Manuscript

The commensal and pathogenic microbial profiles of H and P groups became clearer with
the analysis of the peri-implant core microbiome (Fig. 4). Taxa typically known as hostcompatible, such as Veilonella parvula, S. sanguinis and Rothia sp. were part of the periimplant health core, while the red complex species (T. forsythia, P. gingivalis and T.
denticola), as well as “new putative pathogens” Filifactor alocis, Treponema maltophilum
and Fretibacterium_fastidiosum comprised the peri-implantitis core.
The use of HOMINGS complemented the QIIME data, as it allowed for the species-level
analysis of taxa that could not be “speciated” by QIIME. For instance, QIIME identified
additional taxa from the genus Porphyromonas (Group_4) in the peri-implantitis core
whereas HOMINGS classified some of them as Porphyromonas endodontalis. Similarly, it
identified Campylobacter gracilis and Veillonella dispar as members of the same core, while
QIIME indicated the presence of members of the genera Campylobacter (phylum
Proteobacteria) and Veillonella (Fig. 4, Supplemental Fig. 2).

Author Manuscript

Because HOMINGS is a new bioinformatics approach for the analysis of sequencing data,
we compared its results with those obtained with QIIME, a more established pipeline. Since
QIIME does not allow complete species-level taxonomic resolution, genus-level
comparisons were made. Results were quite comparable and most taxa that differed between
peri-implant health and disease reported in Fig. 1a–c were also observed in the QIIME
pipeline (Supplementary Fig. 3a–c, Supplemental Table 2).

Discussion

Author Manuscript

The use of next generation sequencing to explore the microbiome of healthy and diseased
peri-implant sites allowed us to expand the breadth of knowledge of the etiology of this
disease. We used QIIME and HOMINGS to analyze Illumina MiSeq-generated reads and
demonstrated that QIIME and HOMINGS agreed in large part at the genus level
(Supplemental Table 2). We showed that those pipelines should be complementary: to a
certain extent QIIME provided greater breadth of classification whereas HOMINGS
provided increased precision. We propose that using two accepted and complementary
techniques will shed more light on a difficult (and somewhat ill-defined) classification.
In the present study, we were able to determine major microbial differences between periimplant healthy and diseased sites and delineate the core microbiome of peri-implant health
and peri-implantitis. The microbial differences between the two clinical groups were clear at
all taxonomic levels. Peri-implantitis sites harbored greater levels of members of the phyla
Bacteroidetes, Spirochetes, Synergistetes and Tenericutes, as well as taxa from the genera
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Porphyromonas, Treponema, Filifactor and Fretibacterium. Using fluorescence in situ
hybridization (FISH) combined with epifluorescence microscopy to analyze samples from
the same individuals, Belibasakis and co-workers (Belibasakis et al., 2016) also found
elevated levels of Synergistetes and Spirochetes in peri-implantitis sites. Furthermore,
diseased sites were heavily colonized by traditional pathogens, such as red complex species,
as well as newly proposed pathogenic taxa (Perez-Chaparro et al., 2014), such as F. alocis, F.
fastidiosum and Desulfobulbus sp. oral taxon 041, which is currently uncultured.
Conversely, Streptococci were highly abundant in healthy implants. Our findings corroborate
previous studies suggesting similarities between peri-implant associated microbiota and the
periodontal microbiota. Using checkerboard DNA-DNA hybridization, (Shibli et al., 2008)
found high mean counts of all red complex species in peri-implantitis samples, while hostcompatible microorganisms were reduced. Our results are also in line with early cloning and
sequencing studies of the peri-implant microbiome, in which Porphyromonas,
Fusobacterium and Filifactor species were abundant (da Silva et al., 2014, Koyanagi et al.,
2013).
Several of the traditional pathogens as well as newly proposed pathogenic taxa were
detected in overall low mean relative abundance levels in our study (Fig. 1c, 2a, 2c). Albeit,
similar to levels reported by others (Maruyama et al., 2014), the pathogenic capacity of low
level taxa might be intriguing. However, it is well-accepted that the presence of taxa in low
abundance does not deny their potential importance. In fact, that is the tenet of the keystonepathogen hypothesis, which holds that “certain low-abundance microbial pathogens can
orchestrate inflammatory disease by remodeling a benign microbiota into a dysbiotic one”
(Hajishengallis & Lambris, 2012).
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In our peri-implantitis samples, we could not confirm reports of the presence of bacteria
typically detected in infections of implanted medical devices (Mombelli & Decaillet, 2011)
or species not traditionally associated with periodontitis, including Helicobacter pylori,
Staphylococcus aureus and Staphylococcus anaerobius (Persson & Renvert, 2014), although
H. influenza was part of the peri-implant core microbiome. Our results are also in contrast
with those of (Kumar et al., 2012). Using pyrosequencing, the authors found that periimplantitis harbored lower levels of Prevotella and Leptotrichia and higher levels of
Actinomyces, Peptococcus, Campylobacter, non-mutans Streptococcus, Butyrivibrio and
Streptococcus mutans than healthy implants. A subsequent paper from the same group
(Dabdoub et al., 2013) reported that Staphylococcus was significantly associated with
implant infection and that red complex pathogens were found in only 37 % of the periimplantitis biofilms.
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The discrepancies presented above may be, in part, due to the use of distinct sample
collection methods. While in our study we employed curettes, several publications on the
peri-implant microbiome have used paper points (Dabdoub et al. 2013, Tsigarida et al.
2015). However, this method has been demonstrated to harbor DNA of its own (van der
Horst et al., 2013), which can alter the representation of the microbiome under study,
particularly when sensitive sequencing platforms are used. Thus, their use has been
discouraged, in favor of curettes (van der Horst et al., 2013). The above discrepancies may
also be due to differences in sequencing platforms and bioinformatics pipelines. MiSeq
J Clin Periodontol. Author manuscript; available in PMC 2020 May 08.
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Illumina sequencing has recently outperformed pyrosequencing, allowing an inexpensive
and deeper coverage of the microbiome (Caporaso et al., 2012, Frey et al., 2014, Nelson et
al., 2014, Smith & Peay, 2014). MiSeq technology has a lower error rate compared to
pyrosequencing and generates over 10 times as many reads as 454 GS FLX (Nelson et al.,
2014). Thus, it has become the leading sequencing platform, particularly for human
microbiome sequencing studies (Amarasekara et al., 2015). Furthermore, since our goal was
to define a core microbiome commonly present on implants, and those frequently associated
with peri-implant health or disease only, we used a very conservative approach to assign taxa
as present in our samples. For instance, taxa were removed from consideration if they did
not have at least 3 reads in at least 3 samples in both the healthy and peri-implantitis groups
after rarefication. The goal was to “weed out” species belonging to the so-called “rare
biosphere”. The idea of determining taxa consistently found in human disease conditions or
in specific environments, the so-called core microbiome, has been adopted by many in
microbial ecology (Human Microbiome Project Consortium 2012, Backhed et al., 2012,
Shade & Handelsman, 2012). The use of this approach might have also contributed to
differences between our results and those from previous studies.
While the healthy and peri-implantitis cores were rich in health-compatible and pathogenic
taxa, respectively, we observed that the peri-implant microbiome core contained members of
genera Fusobacterium, Parvimonas and Campylobacter. Interestingly, those genera harbor
species known to be associated with periodontal inflammation (Socransky & Haffajee,
2005), such as F. nucleatum, P. micra and C. rectus, all of which are members of the orange
complex. Hence, it is plausible that implants are colonized by bacterial species that
predispose the adjacent tissues to inflammation.
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In order obtain species-level taxonomic resolution from MiSeq sequencing, we employed
HOMINGS, an in silico 16S rDNA probe analysis that allows the identification of more than
600 oral bacterial species/phylotypes from MiSeq-generated reads (Belstrom et al., 2016a,
Belstrom et al., 2016d). HOMINGS has been validated and has been increasingly used in
oral microbiology studies (Gomes et al., 2015, McIntyre et al., 2016, Mougeot et al., 2017,
Mougeot et al., 2016, Rudney et al., 2015, Timby et al., 2017, Belstrom et al., 2016a,
Belstrom et al., 2016b, Belstrom et al., 2016c, Belstrom et al., 2016d, Belstrom et al., 2017).
Yet, due to the novelty of the use of HOMINGS, we validated our findings by comparing
QIIME and HOMINGS genus-level data (Supplemental Table 2). The results were quite
consistent, indicating the robustness of our analytical pipelines, and the validity of the
HOMINGS technique.
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The combination of these approaches allowed us to detect newly proposed pathogens, such
as P. endododontalis, F. alocis and F. fastidiosum and Desulfobulbus sp oral taxon 041, all
with significant virulence properties. P. endodontalis can induce osteoclastogenesis (Ma et
al., 2017, Yu et al., 2015), F. alocis and P. endodontalis present robust NOD1 and NOD2
stimulatory activity, respectively (Marchesan et al., 2016) and F. alocis has oxidative stress
resistance, neutrophil and macrophage evasion, adhesion and invasion among its main
virulence factors (Aruni et al., 2014). In addition, transcriptional activity analysis of the
periodontal microbiome and the human host in health and chronic periodontitis showed that
the upregulation of bacterial chemotaxis, flagellar assembly, type III secretion system, and
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type III CRISPR-Cas system was driven not only by the red-complex pathogens, but also by
candidate pathogens, including F. alocis and F. fastidiosum (Deng et al., 2017). Finally, our
results suggest that phylotypes, such as Desulfobulbus sp HOT 041, might also contribute to
the development of peri-implantitis. Culture-independent studies have demonstrated the
association of this phylotype with periodontitis (Camelo-Castillo et al., 2015, Oliveira et al.,
2016), however information on its virulence properties is scarce due to its status of “as-ofyet uncultured organism”. Still, the isolation and sequencing of single cells of oral
Desulfobulbus (n = 7) identified genes associated with several categories of putative
virulence factors, including chemotaxis, flagellum biosynthesis motor proteins secretion,
iron acquisition, stress response, evasion, proteases, and adhesion. Collectively, these
findings support the pathogenic role of newly identified pathogens and that they merit
further examination of their potential role as etiologic agents of peri-implantitis.
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The peri-implantitis group included more smokers than the peri-implant healthy group,
which is in line with the literature, as smoking is a well-known risk factor for periimplantitis (Heitz-Mayfield, 2008). Part of the deleterious effects of smoking on implant
survival might be due to its impact on the peri-implant microbiota. As demonstrated by
(Tsigarida et al., 2015), smoking shapes the peri-implant microbiome even in clinical health,
promoting a pathogen-rich community depleted of commensals. This phenomenon was also
observed in the present study, where healthy implants from non-smokers had microbial
profiles distinct from those found in current smokers, which appeared to be more similar to a
peri-implantitis microbiome (Fig. 3 a–c). This finding could help justify the differences in
the core microbiomes in peri-implant health and disease. To examine this possibility, our
statistical models tested for interactions between smoking and disease status. We only found
interactions between smoking and disease status for T. socranskii and E. saphenum, thereby
supporting the notion that the main driver of differences in the core microbiome between
peri-implant health and peri-implantitis was the disease status.
Due to the scarce literature on the comparison of the microbiomes of different implant
systems, we also explored their impact on the local microbiome. Straumann implants were
the most frequently used in both groups (Table 1), but the implant system did not modulate
the microbial composition of peri-implant biofilms (Fig. 3 b–c).
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Although it was not our goal to compare the peri-implant and periodontal microbiota, our
results support the notion that both are similar. Using pyrosequencing, Maruyama and coworkers (Maruyama et al., 2014) performed this comparison and concluded that the core
microbiome associated with these clinical conditions differed, and suggested that they
presented “different causative pathogens”. However, only Prevotella nigrescens had
significantly higher relative abundance in peri-implantitis compared to periodontitis, while
Peptostreptococcaceae [XI] [G-4], sp. HOT369 and Desulfomicrobium orale were more
abundant in periodontitis. Furthermore, their PCoA did not demonstrate that the two diseases
differed in their community structure. Measures of biodiversity were also similar in periimplantitis and periodontitis. Our results were in accordance with theirs that reported that P.
gingivalis, T. denticola and T. socranskii were abundant and prevalent in most samples of
peri-implantitis.
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The present study suggests that the peri-implant microbiome is quite distinct in health and
disease. Peri-implantitis sites showed an enrichment for pathogens, at the expense of a
depletion of host-compatible species. Well-recognized periodontal pathogens as well as
newly proposed pathogenic taxa, several of which have not yet been cultivated, were
associated with peri-implant disease sites. The core peri-implant microbiome contained
members of genera Fusobacterium, Parvimonas and Campylobacter sp., potentially
including pathogenic species such as F. nucleatum, P. micra and C. rectus. Our findings are
clinically relevant, in that based on these results, it can be postulated that close surveillance,
periodic maintenance as well as early diagnosis of peri-implantitis and immediate
intervention are critical for the long-term retention of implants
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Clinical Relevance
Scientific rationale for study: there is a need for a better understanding of the microbial
etiology of peri-implant diseases.
Principal findings: peri-implantitis sites were heavily colonized by well-known and
newly proposed pathogens, including as-of-yet uncultivated taxa, while healthy periimplant sites harbored more commensal taxa. The peri-implant core microbiome was
enriched for Fusobacterium, Parvimonas and Campylobacter species.
Practical implications: Better characterization of the peri-implant microbiome can
improve the understanding of the etiology of peri-implant diseases.
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Figure 1. Box plots of differences in microbial relative abundance between samples from healthy
and peri-implantitis (disease) sites at the level of phylum (a), genus (b), and species (c)

Phylum-, genus- and species-level data were obtained using HOMINGS. Taxa were sorted
according to decreasing relative abundance in subjects with peri-implantitis. Only taxa that
were significantly different between the healthy and peri-implantitis groups (with FDRadjusted p-values <0.05) in more than 95% of the 100 iterations performed were plotted.
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Figure 2. Relative abundance of pathogenic and health-compatible species in individual implants

Graphs show mean relative abundance (%) for (a) well-recognized periodontal pathogens,
(b) putative commensals and (c) newly proposed pathogenic taxa. Only species that were
significantly different between the healthy and peri-implantitis groups (with FDR-adjusted
J Clin Periodontol. Author manuscript; available in PMC 2020 May 08.
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p-values <0.05) in more than 98% of the 100 iterations performed were plotted. Each bar
represents one individual healthy (blue) or diseased (red) implant.
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Figure 3. Principal Coordinate Analysis (PCoA) of the microbial composition of samples
according to disease status (a), smoking habit (b) and brand of implant (c)

Author Manuscript

Graphs represent the PCoA plots of Bray–Curtis distances based on species level data
generated with HOMINGS. Samples from subjects presenting healthy (blue) and diseased
(red) peri-implant sites (a) are plotted according to smoking habit (b) and type of implant
(c).
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Figure 4. Core Microbiome
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Taxa that were present with ≥ 0.1% relative abundance in ≥ 50% of all samples according to
HOMINGS results constitute the core microbiome (blue). Samples were divided into those
representing healthy or peri-implantitis. The core microbiome was subdivided into 4 groups
based on the mean relative abundance of the taxa in samples in each clinical category. Taxa
that were present in ≥ 50% of samples in a single category, but were not part of the core
microbiome considering all samples, constituted the Healthy (green) or Peri-implantitis (red)
core microbiomes. Taxa in those core microbiomes were sub-grouped based on the mean
relative abundance of the taxa in samples in each clinical group. Taxa in bold were present in
≥ 75% of all samples (Core).
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Characteristics of the peri-implant sites sampled.
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Note: PD=pocket depth, BOP=bleeding on probing, PI=plaque index, SD=standard deviation.
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